Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn's Disease: Results of the PYRAMID Registry.

EV, Loftus; W, Reinisch; R, Panaccione; S, Berg; G, Alperovich; M, Bereswill; J, Kalabic; J, Petersson; R, Thakkar; AM, Robinson; G, D'Haens

doi:10.1093/ibd/izz008

Public

Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn's Disease: Results of the PYRAMID Registry.

Shared by NobleBlocks on Aug 1, 2019 • 12:00 AM UTC

Authors:

Loftus EV

Reinisch W

Panaccione R

Abstract

<h4>Background</h4>PYRAMID was an international multicenter, noninterventional, postmarketing registry assessing long-term safety and effectiveness of adalimumab (Humira), as used in routine clinical practice.<h4>Methods</h4>Adult patients with moderately to severely active Crohn's disease with or w...

Subject

Clinical practice

Long-term Effectiveness

Disease Activity

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!